Episode Details
Back to Episodes
EP134: Discussing Statin Intolerance With Dr. Karam Kostner
Description
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Podcast Summary
Introduction
Dr. Warrick Bishop, a practicing cardiologist and author, hosts this episode with guest Dr. Karam Kostner, a lipid expert and cardiologist from Queensland. The discussion focuses on statin intolerance—a common concern among patients—exploring its definition, prevalence, and practical management strategies in clinical practice.
Key Takeaways:
-
Statin intolerance is defined as the inability to tolerate at least two different statins due to clinical side effects, though true intolerance is less common than patients perceive.
-
Muscle pain occurs in approximately 5% of statin users taking higher doses (atorvastatin 80mg, rosuvastatin 40mg), but most musculoskeletal pain is coincidental rather than statin-caused.
-
Rhabdomyolysis, the most serious muscle-related side effect, is extremely rare (approximately 1 in 10,000 to 1 in 80,000 patients) and involves significant muscle pain with CK elevation of 5-10 fold above normal limits.
-
Statins actually prevent vascular dementia and cognitive decline in most patients; short-term memory loss attributed to statins is extremely rare despite popular concerns.
-
Studies show that in a placebo-controlled challenge, approximately 75% of patients reporting statin intolerance could tolerate statins when blinded, while only 25% experienced genuine side effects.
-
Different statins carry different risk profiles; older statins like fluvastatin and pravastatin show lower muscle-related side effects compared to high-dose atorvastatin and rosuvastatin.
-
While statins may slightly increase glucose levels in pre-diabetic patients, this small risk is offset by cardiovascular benefits in diabetic patients.
-
Clinical management strategies include trying multiple statins at varying doses, using low-dose statins three times weekly, and adding ezetrol to achieve cholesterol targets.
-
Magnesium orotate (800-1200mg daily) is an evidence-based, safe, and cost-effective supplement that reduces statin-related muscle symptoms in many patients.
-
Coenzyme Q10 supplementation may help some patients resistant to magnesium, though conclusive evidence from large trials is limited.